These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 12085180)
1. Cytokeratin 7 and 20 staining for the diagnosis of lung and colorectal adenocarcinoma. Kummar S; Fogarasi M; Canova A; Mota A; Ciesielski T Br J Cancer; 2002 Jun; 86(12):1884-7. PubMed ID: 12085180 [TBL] [Abstract][Full Text] [Related]
2. [Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung]. Zou SM; Lin DM; Lü N; Liu XY; Wen P; Liu FS Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1350-2. PubMed ID: 12930693 [TBL] [Abstract][Full Text] [Related]
3. Combined immunohistochemistry of beta-catenin, cytokeratin 7, and cytokeratin 20 is useful in discriminating primary lung adenocarcinomas from metastatic colorectal cancer. Ikeda S; Fujimori M; Shibata S; Okajima M; Ishizaki Y; Kurihara T; Miyata Y; Iseki M; Shimizu Y; Tokumoto N; Ozaki S; Asahara T BMC Cancer; 2006 Feb; 6():31. PubMed ID: 16451736 [TBL] [Abstract][Full Text] [Related]
4. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens. Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468 [TBL] [Abstract][Full Text] [Related]
5. Cytokeratin staining for primary and metastatic colorectal cancer. Kummar S; Ciesielski TE Clin Colorectal Cancer; 2001 Nov; 1(3):187-8. PubMed ID: 12450437 [TBL] [Abstract][Full Text] [Related]
6. CDX-2, cytokeratin 7 and cytokeratin 20 immunohistochemical expression in the differential diagnosis of primary adenocarcinomas of the sinonasal tract. Franchi A; Massi D; Palomba A; Biancalani M; Santucci M Virchows Arch; 2004 Jul; 445(1):63-7. PubMed ID: 15175880 [TBL] [Abstract][Full Text] [Related]
7. The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas. Tot T Cancer; 2001 Nov; 92(10):2727-32. PubMed ID: 11745209 [TBL] [Abstract][Full Text] [Related]
8. Villin, cytokeratin 7, and cytokeratin 20 expression in pulmonary adenocarcinoma with ultrastructural evidence of microvilli with rootlets. Tan J; Sidhu G; Greco MA; Ballard H; Wieczorek R Hum Pathol; 1998 Apr; 29(4):390-6. PubMed ID: 9563790 [TBL] [Abstract][Full Text] [Related]
9. Primary cervical adenocarcinoma with intestinal differentiation and colonic carcinoma metastatic to cervix: an investigation using Cdx-2 and a limited immunohistochemical panel. Raspollini MR; Baroni G; Taddei A; Taddei GL Arch Pathol Lab Med; 2003 Dec; 127(12):1586-90. PubMed ID: 14632574 [TBL] [Abstract][Full Text] [Related]
10. Utility of thyroid transcription factor-1 and cytokeratin 7 and 20 immunostaining in the identification of origin in malignant effusions. Jang KY; Kang MJ; Lee DG; Chung MJ Anal Quant Cytol Histol; 2001 Dec; 23(6):400-4. PubMed ID: 11777274 [TBL] [Abstract][Full Text] [Related]
11. Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma. Shah RN; Badve S; Papreddy K; Schindler S; Laskin WB; Yeldandi AV Hum Pathol; 2002 Sep; 33(9):915-20. PubMed ID: 12378517 [TBL] [Abstract][Full Text] [Related]
12. Utility of tissue-specific transcription factors thyroid transcription factor 1 and Cdx2 in determining the primary site of metastatic adenocarcinomas to the brain. Strickland-Marmol LB; Khoor A; Livingston SK; Rojiani A Arch Pathol Lab Med; 2007 Nov; 131(11):1686-90. PubMed ID: 17979487 [TBL] [Abstract][Full Text] [Related]
13. Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas. Loy TS; Calaluce RD Am J Clin Pathol; 1994 Dec; 102(6):764-7. PubMed ID: 7528468 [TBL] [Abstract][Full Text] [Related]
14. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma. Su YC; Hsu YC; Chai CY Kaohsiung J Med Sci; 2006 Jan; 22(1):14-9. PubMed ID: 16570563 [TBL] [Abstract][Full Text] [Related]
15. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody. Bayrak R; Haltas H; Yenidunya S Diagn Pathol; 2012 Jan; 7():9. PubMed ID: 22268990 [TBL] [Abstract][Full Text] [Related]
16. Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma. Saad RS; Cho P; Silverman JF; Liu Y Am J Clin Pathol; 2004 Sep; 122(3):421-7. PubMed ID: 15362373 [TBL] [Abstract][Full Text] [Related]
17. Lung adenocarcinomas metastatic to the brain with and without ultrastructural evidence of rootlets: an electron microscopic and immunohistochemical study using cytokeratins 7 and 20 and villin. Sharma S; Tan J; Sidhu G; Wieczorek R; Miller DC; Cassai ND Ultrastruct Pathol; 1998; 22(5):385-91. PubMed ID: 9887481 [TBL] [Abstract][Full Text] [Related]
18. [Immunohistochemical profile of colorectal and ovarian carcinomas--examination with cytokeratin 7, cytokeratin 20, beta catenin and cDX 2]. Porjazova E; Zaprjanov Z; Batashki I; Markova D; Milchev N Akush Ginekol (Sofiia); 2009; 48(2):7-12. PubMed ID: 20198769 [TBL] [Abstract][Full Text] [Related]
19. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites. Lagendijk JH; Mullink H; Van Diest PJ; Meijer GA; Meijer CJ Hum Pathol; 1998 May; 29(5):491-7. PubMed ID: 9596273 [TBL] [Abstract][Full Text] [Related]
20. The clinical relevance of cytokeratin phenotyping in needle biopsy of liver metastasis. Tot T; Samii S APMIS; 2003 Dec; 111(12):1075-82. PubMed ID: 14678015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]